NEIL1 and cancer: Since a reduction in NEIL1 expression was associated with an increased somatic mutation level and mutations in cancer-associated genes can lead to the exaggeration of the malignant potential, such as an increase in the proliferation rate, this kind of phenotypic change might explain the difference in survival outcomes between patients with and those without a reduction in NEIL1 expression.